DUBLIN–(BUSINESS WIRE)–Jan 29, 2021–
The "Implantable Drug Delivery Devices – Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com’s offering.
Global Implantable Drug Delivery Devices Market to Reach $30.2 Billion by 2027
Amid the COVID-19 crisis, the global market for Implantable Drug Delivery Devices estimated at US$20 Billion in the year 2020, is projected to reach a revised size of US$30.2 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027.
Contraceptive Implants, one of the segments analyzed in the report, is projected to record a 6.3% CAGR and reach US$7.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Spinal Implants segment is readjusted to a revised 5.7% CAGR for the next 7-year period.
The U. S. Market is Estimated at $5.9 Billion, While China is Forecast to Grow at 5.7% CAGR
The Implantable Drug Delivery Devices market in the U. S. is estimated at US$5.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.
Brachytherapy Seeds Segment to Record 6.1% CAGR
In the global Brachytherapy Seeds segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$920.1 Million in the year 2020 will reach a projected size of US$1.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.5 Billion by the year 2027.
The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
- Abbott Laboratories
- Allergan PLC
- Bausch and Lomb, Inc.
- Bayer AG
- Boston Scientific Corporation
- Medtronic PLC
- Merck & Co., Inc.
- Teleflex, Inc.
- Varian Medical Systems, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Implantable Drug Delivery Devices Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
- Market Facts & Figures
- US Implantable Drug Delivery Devices Market Share (in %) by Company: 2019 & 2025
- Market Analytics
CANADA
JAPAN
CHINA
EUROPE
- Market Facts & Figures
- European Implantable Drug Delivery Devices Market: Competitor Market Share Scenario (in %) for 2019 & 2025
- Market Analytics
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
IV. COMPETITION
- Total Companies Profiled: 46
For more information about this report visit https://www.researchandmarkets.com/r/gval2f
View source version on businesswire.com:https://www.businesswire.com/news/home/20210129005227/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 01/29/2021 05:49 AM/DISC: 01/29/2021 05:49 AM
http://www.businesswire.com/news/home/20210129005227/en
